2C-C: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Research Materials -> Research chemicals |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid, limited data)"> | |||
Erowid's dosage documentation for oral 2C-C<ref name="erowid-2cc-dose"> | |||
Erowid. 2C-C Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2cc/2cc_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers; Erowid notes | |||
explicitly that "very few reports of 2C-C usage" exist and dosages | |||
"are not well known": | |||
* '''Light:''' 15-25 mg | |||
* '''Common:''' 25-35 mg | |||
* '''Strong:''' 35-55 mg | |||
Threshold and heavy tiers are not characterized. Duration approximately | |||
3 to 5 hours. Erowid's limited-data caveat should be reflected in any | |||
presentation of these figures. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||